In his papers, Hideki Enokida integrates diverse fields, such as Cancer and Cell growth. He undertakes interdisciplinary study in the fields of Cell growth and Gene through his works. In his works, Hideki Enokida conducts interdisciplinary research on Gene and In silico. He performs integrative study on Cancer research and Carcinogenesis. He undertakes interdisciplinary study in the fields of Carcinogenesis and Cancer research through his works. His work on In silico expands to the thematically related Genetics. Hideki Enokida performs integrative study on microRNA and Messenger RNA in his works. In his papers, Hideki Enokida integrates diverse fields, such as Messenger RNA and microRNA. His Bladder cancer study frequently draws connections to adjacent fields such as Transitional Cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Small dsRNAs induce transcriptional activation in human cells
Long-Cheng Li;Steven T. Okino;Hong Zhao;Deepa Pookot.
Proceedings of the National Academy of Sciences of the United States of America (2006)
miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma
Masayuki Kano;Naohiko Seki;Naoko Kikkawa;Lisa Fujimura.
International Journal of Cancer (2010)
Identification of novel microRNA targets based on microRNA signatures in bladder cancer.
Takahiro Ichimi;Hideki Enokida;Yasushi Okuno;Ryo Kunimoto.
International Journal of Cancer (2009)
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer
T Chiyomaru;H Enokida;S Tatarano;K Kawahara.
British Journal of Cancer (2010)
The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer
H Yoshino;T Chiyomaru;H Enokida;K Kawakami.
British Journal of Cancer (2011)
microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers
Nijiro Nohata;Toyoyuki Hanazawa;Hideki Enokida;Naohiko Seki.
MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology
Yasutoshi Yamada;Hideki Enokida;Satoko Kojima;Kazumori Kawakami.
Cancer Science (2011)
Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR
Takeshi Chiyomaru;Soichiro Yamamura;Shinichiro Fukuhara;Hirofumi Yoshino.
PLOS ONE (2013)
Epigenetic Inactivation of Wnt Inhibitory Factor-1 Plays an Important Role in Bladder Cancer through Aberrant Canonical Wnt/β-Catenin Signaling Pathway
Shinji Urakami;Hiroaki Shiina;Hideki Enokida;Toshifumi Kawakami.
Clinical Cancer Research (2006)
Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer.
Takashi Tokizane;Hiroaki Shiina;Mikio Igawa;Hideki Enokida.
Clinical Cancer Research (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: